Benzinga | Aug 4, 2021 10:55AM EDT

Horizon Therapeutics Earlier Reported Q2 EPS $1.62 Beats $0.88 Estimate, Sales $832.55M Beat $685.03M Estimate

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $0.88 by 84.09 percent. This is a 305 percent increase over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $832.55 million which beat the analyst consensus estimate of $685.03 million by 21.53 percent. This is a 79.90 percent increase over sales of $462.78 million the same period last year.